Topic

Floaters and discomfort in an immunocompetent patient

How to follow the diagnostic clues and clinch the diagnosis.

How to recognize predictors of spontaneous macular hole closure

A review of anatomical characteristics of holes more likely to close without surgery and noninterventional management options.

Morning Glory Syndrome

Imaging is key to correctly diagnosing this optic disc anomaly.

Acute macular neuroretinopathy

OCT is invaluable in diagnosing, managing, and understanding this condition.

Beyond structural retinal imaging: Adaptive optics fluorescence lifetime ophthalmoscopy (AOFLIO)

Visualizing potential biomarkers for changes in cellular function across the retina.

An atypical presentation of ocular toxoplasmosis

Diagnostic testing and multimodal imaging may help avoid a delay in treatment.

Lessons from Protocol AA for UWF imaging in DR

How to use the DRCR Retina Network roadmap for ultra-widefield imaging to evaluate eyes with nonproliferative diabetic retinopathy.

The dark side of pentosan

The vision consequences of a long-discontinued treatment for interstitial cystitis.

3D heads-up visualization: Less pain, more gain

Three-dimensional heads-up display can enhance surgical visualization, training, ergonomics and potentially surgical outcomes.

Practical applications of intraoperative OCT

A review of how it can be used for multiple retinal procedures, with more coming as technology advances.

Using OCT to identify biomarkers of early DR

Exploring the potential of optical coherence tomography to evaluate photoreceptor health before signs and symptoms of diabetic retinopathy manifest.

The potential of mitochondrial FPF imaging in practice

Flavoprotein fluorescence imaging is a novel modality that can detect subtle functional alterations that may precede structural changes in the retina.

Solving the masquerade of vitreoretinal lymphoma

A case-based review of biopsy techniques from vitreous sampling to more invasive approaches.

Slithering toward the fovea

How multimodal imaging aids in the crucial differentiation of serpiginous choroiditis from serpiginous-like choroiditis.

The dichotomy of didanosine

Even years after discontinuation, a life-saving drug for HIV patients can have deleterious effects on vision.

Comparing techniques for RRD, MH

Prime cuts from ASRS also include a quick-response program for CRAO, and trials of agents for GA and mydriasis reversal.

Epitheliopathy after a COVID-19 vaccine

Flashing spots and whitish blots: How OCTA can aid in diagnosis and surveillance.

A ser(i)ous detachment

How multimodal imaging and systemic examination helped uncover the underlying etiology of a longstanding choroidal neovascular membrane.

Peripheral lesions take DR imaging beyond ETDRS

Ultra-widefield imaging and artificial intelligence have called into question standards based on film photography.

Vision loss tied to cancer history

How imaging helped diagnose the cause of vision problems in a woman with endometrial adenocarcinoma.

Who’s predisposed to anti-VEGF-induced IOI?

What clinical trials and postmarket data reveal about intraocular inflammation risk with brolucizumab.

Understanding the risks of systemic vascular disease

The retina is the canary in the coal mine for evaluating future systemic vascular disease in people with diabetes.

Making the retina workplace more ergonomically friendly

How a few modifications in the clinic and OR—and perhaps some yoga—can help overcome occupational aches and pains.

Not just pigments of your imagination

A case of idiopathic intrigue requiring investigation of an inflammatory cause.

Using OCT to evaluate fluid in non-neovascular AMD

How optical coherence tomography, OCT angiography and fluorescein angiography can help direct diagnosis and treatment decisions.

How imaging is advancing management of dry AMD

Emerging modalities and deep learning are helping to expose an old foe in non-neovascular age-related macular degeneration: reticular pseudodrusen.

Imaging biomarkers and precision medicine

Advances in computational power, and machine learning and diagnostic systems are creating new opportunities for understanding disease mechanisms.

Will biosimilars find their place in retina?

With patents expiring, an approval pending and legislation aimed at easing regulations, more biosimilars could be coming. But are retina specialists ready?

Retinal sequelae of novel oncology drugs

Getting to the cause of blurred vision in a man with Erdheim-Chester disease.

AI in retina: Ready for prime time?

Artificial intelligence is ready to be incorporated into retina referral networks. Here’s a look at the state of the science.

A novel approach to MH-RD in an infant